All stock lists
Masco Corp /De/ (New York Stock Exchange:MAS)
US · Delayed Price · Currency is USD
Also listed: 0JZ1.LBasic Materials · Construction Materials
82.18-1.33 (-1.60%)
Market cap
$15.8B
Insider Score
Health Score
Analyst consensus
Listed since
Mar 17, 1980
Website
Insider Score
––Not scored
MAS Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
MAS analyst forecast
MAS analyst consensus
Moderate Buy7 ratings
Buy 4 Hold 3 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
MAS 12-month price target
$86.00+4.7% upsideaverage of 2 firms
$90.00High
$82.00Low
MAS ratings mix, last 12 months
Buy Hold Sell
Best analysts covering MAS
- Oppenheimer100%success rate · +13.0% avg return · 1 call
- Argus Research100%success rate · +31.4% avg return · 1 call
- UBS67%success rate · +4.8% avg return · 6 calls
- Truist Securities67%success rate · +16.5% avg return · 6 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
MAS analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | UBS | Buy | — | — | Reiterated | 2026-10-29 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2026-10-29 |
| — | Baird | Neutral | — | — | Reiterated | 2026-10-29 |
| Oppenheimer | Outperform | $90.00 | +18.3% | Reiterated | 2026-10-29 | |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-10-29 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-10-29 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-10-29 |
| D.A. Davidson | — | $82.00 | +7.8% | — | 2026-10-29 | |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2026-10-07 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-09-11 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-07-31 |
| — | UBS | Buy | — | — | Reiterated | 2026-07-30 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-07-30 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-07-30 |
| — | Evercore ISI Group | In Line | — | — | Downgraded | 2026-07-30 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-07-14 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-07-14 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2026-04-24 |
| — | BMO Capital | Market Perform | — | — | Reiterated | 2026-04-24 |
| — | Baird | Neutral | — | — | Reiterated | 2026-04-23 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2026-04-23 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-04-23 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-04-23 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-04-23 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2026-04-23 |
| — | UBS | Buy | — | — | Reiterated | 2026-04-23 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2026-04-23 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-04-23 |
| — | Baird | Neutral | — | — | Reiterated | 2026-04-21 |
| — | B of A Securities | Underperform | — | — | Reiterated | 2026-04-20 |
| — | BMO Capital | Market Perform | — | — | Reiterated | 2026-04-20 |
| — | Evercore ISI Group | Outperform | — | — | Upgraded | 2026-04-13 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-04-08 |
| — | Barclays | Equal Weight | — | — | Reiterated | 2026-04-08 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-02-12 |
| — | Evercore ISI Group | In Line | — | — | Reiterated | 2026-02-11 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-02-11 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2026-02-11 |
| — | Wells Fargo | Overweight | — | — | Reiterated | 2026-01-14 |
| — | Citigroup | Neutral | — | — | Reiterated | 2026-01-08 |
| — | Wells Fargo | Overweight | — | — | Upgraded | 2025-12-15 |
| — | Barclays | Equal Weight | — | — | Downgraded | 2025-12-08 |
| — | Argus Research | Buy | — | — | Reiterated | 2025-11-05 |
| — | Evercore ISI Group | In Line | — | — | Reiterated | 2025-10-30 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-10-30 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2025-10-30 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-10-30 |
| — | UBS | Buy | — | — | Reiterated | 2025-10-30 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-09-11 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2025-08-04 |
| — | Loop Capital | Hold | — | — | Reiterated | 2025-08-04 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2025-08-04 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-08-01 |
| — | RBC Capital | Sector Perform | — | — | Reiterated | 2025-08-01 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-07-15 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2025-05-14 |
| — | Baird | Outperform | — | — | Reiterated | 2025-04-24 |
| — | Evercore ISI Group | In Line | — | — | Reiterated | 2025-04-24 |
| — | UBS | Buy | — | — | Reiterated | 2025-04-24 |
| — | Goldman Sachs | Buy | — | — | Reiterated | 2025-04-24 |
MAS earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-10 | 0.78 | 0.82 | $1.82B | $1.79B |
| 2026-04-22 | 0.88 | 1.04 | $1.83B | $1.92B |
| 2026-07-29 | 1.32 | 1.64 | $2.08B | $1.99B |
| 2026-10-28 | 1.02 | 1.19 | $1.93B | $1.97B |
| 2027-02-09Upcoming | 0.85 | — | $1.84B | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.